Align Technology tumbles 34.2% after Q2 earnings and revenues miss estimates as Clear Aligner sales drop and margins tighten further.
Align Technology, Inc. (NASDAQ:ALGN ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants John F. Morici - CFO & Executive VP of Global Finance Joseph M.
The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Align Technology (ALGN) came out with quarterly earnings of $2.49 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.41 per share a year ago.
ALGN is likely to have delivered robust Q2 2025 performance as Invisalign traction and iTero upgrades gained steam across global markets.
Align Technology (ALGN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ALGN broke through the 200-day moving average, which suggests a long-term bullish trend.
From a technical perspective, Align Technology (ALGN) is looking like an interesting pick, as it just reached a key level of support. ALGN recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Align Technology (ALGN) and Straumann Holding AG (SAUHY). But which of these two stocks offers value investors a better bang for their buck right now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Align Technology (ALGN) or Straumann Holding AG (SAUHY). But which of these two stocks presents investors with the better value opportunity right now?
ALGN's Invisalign growth, iTero innovation and solid finances fuel optimism despite forex headwinds.
Align Technology is transitioning from a device maker to a digital dentistry platform, leveraging AI software and recurring service revenues. The market undervalues ALGN, pricing it as a consumer product company despite its slow transition to higher-margin, recurring digital services. Expansion into restorative dentistry and new patient segments increases ALGN's addressable market and raises switching costs for dental clinics.